NASDAQ:AKBA | Cash Flow Statement | Akebia Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$8.91M
2026-03-31-$9.05M-$21.21M$62,000.00-$62,000.00-$926,000.00
2025-12-31-$12.24M$31.13M$70,000.00-$7.88M-$4.85M
2025-09-30$540,000.00
2025-06-30$247,000.00
2025-03-31$6.11M-$13.59M$18,000.00$154,000.00$74.94M
2024-12-31-$22.8M-$4.47M$2,000.00-$2,000.00$22.33M
2024-09-30-$20.04M
2024-06-30-$8.58M
2024-03-31-$17.99M-$19.43M$0.00$0.00$18.48M
2023-12-31$614,000.00-$2.31M$0.00$0.00-$1.29M
2023-09-30-$14.49M
2023-06-30-$11.17M
2023-03-31-$26.88M-$17.54M$0.00$0.00-$15.97M
2022-12-31-$6.07M-$54.68M$0.00$0.00-$1,000.00
2022-09-30-$54.1M
2022-06-30$29.45M
2022-03-31-$63.51M-$21.62M$114,000.00-$114,000.00$47.55M
2021-12-31-$70.68M-$62.81M$0.00$0.00$5.4M
2021-09-30-$59.54M
2021-06-30-$83.04M
2021-03-31-$69.58M-$70.75M$59,000.00$19.94M$74.48M
2020-12-31-$87M-$30.78M$317,000.00$59.68M$30.51M
2020-09-30-$59.96M
2020-06-30-$175.75M
2020-03-31-$60.75M$525,000.00-$89.59M$0.00$245,000.00$57.35M
2019-12-31-$94.48M$586,000.00-$92.14M$220,000.00$22.28M$94.42M
2019-09-30-$54.59M
2019-06-30-$58.17M
2019-03-31-$72.42M$439,000.00-$137.93M$1.93M$110.47M-$14.45M
2018-12-31-$60.05M$261,000.00-$73.7M$830,000.00$16.72M$85,000.00
2018-09-30-$26.05M
2018-06-30-$34.07M
2018-03-31-$23.42M$199,000.00-$20.33M$296,000.00$12.43M$95.91M
2017-12-31$15.52M$197,000.00-$16.38M$450,000.00-$8.31M$5.24M
2017-09-30-$23.13M
2017-06-30-$21.52M
2017-03-31-$44.54M$135,000.00-$9.53M$427,000.00
2016-12-31-$37.86M$124,000.00$95.67M$48,000.00
2016-09-30-$36.31M
2016-06-30-$35.78M
2016-03-31-$25.8M$32,000.00$17.43M$109,000.00
2015-12-31-$19.86M$11,000.00-$22.91M$72,000.00
2015-09-30-$19.48M
2015-06-30-$10.69M
2015-03-31-$10.7M-$8.35M$200,000.00
2014-12-31-$10.37M-$9.2M$21,000.00$83,000.00
2014-09-30-$9.35M
2014-06-30-$7.62M
2014-03-31-$9.7M-$6.01M$142,000.00
2013-12-31-$5.95M-$4.91M$13,000.00
2013-09-30-$3.77M
2013-06-30-$2.83M
2013-03-31-$620,914.00-$1.53M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$5.35M$67.99M$291,000.00-$7.93M$72.93M
2024-12-31-$69.41M-$40.66M$33,000.00-$33,000.00$49.66M
2023-12-31-$51.93M-$23.38M$0.00$0.00-$25.21M
2022-12-31-$94.23M$1.65M-$73.15M$114,000.00-$114,000.00$14.6M
2021-12-31-$282.84M$1.93M-$252.97M$59,000.00$39.94M$133.73M
2020-12-31-$383.46M$2.08M-$110.39M$317,000.00-$40M$231.72M
2019-12-31-$279.66M$2.25M-$257.44M$6.66M$211.18M$88.97M
2018-12-31-$143.59M$899,000.00-$97.49M$1.61M$36.59M$96.56M
2017-12-31-$73.67M$617,000.00-$56.16M$1.62M-$177.26M$116.24M
2016-12-31-$135.75M$296,000.00$57.91M$2.66M$12.71M$66.95M
2015-12-31-$60.72M$96,000.00-$52.41M$414,000.00
2014-12-31-$37.03M$49,000.00-$27.48M$229,000.00$162,000.00
2013-12-31-$13.17M-$11.33M$19,000.00
2012-12-31-$8.2M-$7.21M